Joyce Pagan

May 14, 2024 | oncologynurseadvisor.com | Joyce Pagan

Select sessions from the 9th annual Oncology Nurse Advisor (ONA) Summit live virtual meeting are available on-demand at myCME until April 2025. Nurses can access and complete activities, earning up to 6.5 contact hours certified by the American Nurses Credentialing Center (ANCC) and the American Association of Nurse Practitioners (AANP).

Mar 4, 2024 | hematologyadvisor.com | Joyce Pagan

Higher out-of-pocket costs, prolonged hospital stays and intensive follow-up, and potential treatment-related complications increase risk of financial toxicity (FT) in patients with hematologic cancer, especially those undergoing bone marrow transplantation (BMT).  Those same factors were also found to increase risk of FT in the caregivers of this patient population, according to a study published in Psycho-Oncology.

Dec 21, 2023 | hematologyadvisor.com | Joyce Pagan

Whether a patient used an approach-oriented or avoidant coping strategy was associated with quality of life (QOL) and psychological distress in those with hematologic malignancies undergoing hematopoietic cell transplantation (HCT). These findings were presented at the ASH Annual Meeting 2023. Physical and psychological symptoms during hospitalization for HCT can dramatically reduce QOL for patients undergoing the procedure.

Dec 10, 2023 | brnw.ch | Joyce Pagan

Whether a patient used an approach-oriented or avoidant coping strategy was associated with quality of life (QOL) and psychological distress in those with hematologic malignancies undergoing hematopoietic cell transplantation (HCT). These findings were presented at the ASH Annual Meeting 2023. Physical and psychological symptoms during hospitalization for HCT can dramatically reduce QOL for patients undergoing the procedure.

Dec 10, 2023 | oncologynurseadvisor.com | Joyce Pagan

Whether a patient used an approach-oriented or avoidant coping strategy was associated with quality of life (QOL) and psychological distress in those with hematologic malignancies undergoing hematopoietic cell transplantation (HCT). These findings were presented at the ASH Annual Meeting 2023. Physical and psychological symptoms during hospitalization for HCT can dramatically reduce QOL for patients undergoing the procedure.